| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Atlas Critical Minerals raises $11 million in upsized public offering | ||
| Mo | MKS to showcase photonics innovations at Photonics West 2026 | ||
| Mo | Charles River Labs to acquire K.F. Cambodia and PathoQuest SAS | ||
| Mo | Chipotle names Eskenazi as chief legal and human resources officer | ||
| Mo | Raymond James reiterates Strong Buy on Cogent stock with $60 price target | ||
| Mo | Zscaler names Kocherlakota to lead new agentic AI security division | ||
| Mo | Pool Corporation announces leadership changes as St. Romain to retire | ||
| Mo | Crown Castle terminates DISH Wireless deal after payment default | ||
| Mo | BioMarin appoints Arpit Davé as chief digital and information officer | ||
| Mo | Five9 expands partnership with Google Cloud for enterprise CX AI | ||
| Mo | SciSparc receives Nasdaq non-compliance notice for stockholders' equity | ||
| Mo | ServiceNow executive Paul Fipps joins NetApp's board of directors | ||
| Mo | NETSTREIT completes record $657.1 million investment activity in 2025 | ||
| Mo | FrontView REIT reports $124.1 million in acquisitions for 2025 | ||
| Mo | Coherent launches optical filter with industry-leading resolution | ||
| Mo | BMO Capital reiterates Outperform rating on Roblox stock at $155 | ||
| Mo | Revolution Medicines stock gains as Stifel highlights strong PDAC position | ||
| Mo | Alphatec stock price target maintained at $25 by Canaccord on strong results | ||
| Mo | Evercore ISI reiterates Outperform rating on Apple stock amid Google AI deal | ||
| Mo | Alphatec stock steady despite Q4 growth deceleration, Stifel reports | ||
| Mo | Baird raises Mirum Pharmaceuticals stock price target to $95 on strong sales | ||
| Mo | Lafayette Digital Acquisition Corp. I closes $287.5 million IPO | ||
| Mo | Genesco stock price target raised to $32 by Jefferies on strong holiday sales | ||
| Mo | Ondas Holdings raises $959.2 million in registered direct offering | ||
| Mo | Outset Medical stock beats Q4 sales estimates, reaches high end of 2025 guidance |